The Caledonian-Record

U.S. FDA Accepts Takeda's Application for Intravenous ENTYVIO® (vedolizumab) in Pediatric ...

ENTYVIO is currently approved for the treatment of moderately to severely active UC and Crohn’s disease in adults.